97
Views
10
CrossRef citations to date
0
Altmetric
Review

Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction

Pages 3189-3198 | Accepted 24 Sep 2007, Published online: 07 Nov 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paolo Capogrosso, Eugenio Ventimiglia, Luca Boeri, Alessandro Serino, Andrea Russo, Giovanni La Croce, Umberto Capitanio, Federico Dehò, Francesco Montorsi & Andrea Salonia. (2017) Time of onset of vardenafil orodispersible tablet in a real-life setting – looking beyond randomized clinical trials. Expert Review of Clinical Pharmacology 10:3, pages 339-344.
Read now
Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Alessandro Serino, Giovanni La Croce, Andrea Russo, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Avanafil - a further step to tailoring patient needs and expectations. Expert Review of Clinical Pharmacology 9:9, pages 1171-1181.
Read now
Martin Miner & Wayne J. G. Hellstrom. (2008) Distinguishing Premature Ejaculation from Other Sexual Function Disorders. Postgraduate Medicine 120:1, pages 54-63.
Read now

Articles from other publishers (7)

Donald J. AbrahamDavid P. Rotella. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 19 .
Dimitrios Hatzichristou, Gianluca d’Anzeo, Hartmut Porst, Jacques Buvat, Carsten Henneges, Andrea Rossi, Karim Hamidi & Hartwig Büttner. (2015) Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urology 15:1.
Crossref
Angelina Sontag, Raymond C. Rosen, Heather J. Litman, Xiao Ni & Andre B. Araujo. (2013) The Role of Initial Success Rates and Other Factors in Determining Reliability of Outcomes of Phosphodiesterase Inhibitor Therapy for Erectile Dysfunction: A Pooled Analysis of 17 Placebo‐Controlled Trials of Tadalafil for Use as Needed. The Journal of Sexual Medicine 10:2, pages 541-550.
Crossref
Thomas G. Travison, Susan A. Hall, William A. Fisher, Andre B. Araujo, Raymond C. Rosen, John B. McKinlay & Michael S. Sand. (2011) Correlates of PDE5i Use Among Subjects with Erectile Dysfunction in Two Population-Based Surveys. The Journal of Sexual Medicine 8:11, pages 3051-3057.
Crossref
Frans M.J. Debruyne, Marc Gittelman, Herbert Sperling, Matthias Börner & Manfred Beneke. (2011) Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film-Coated Tablet Formulations. The Journal of Sexual Medicine 8:10, pages 2912-2923.
Crossref
A. Martín-Morales, A. Graziottin, G. B. Jaoudé, F. Debruyne, J. Buvat, M. Beneke & D. Neuser. (2011) Improvement in Sexual Quality of Life of the Female Partner Following Vardenafil Treatment of Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Sexual Medicine 8:10, pages 2831-2840.
Crossref
Donald J. AbrahamDavid P. Rotella. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 693 710 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.